JOHANNESBURG (AP) — Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV ...

The BRILLIANT program is scrambling to find money to save the project. The purchase of key equipment has stopped.

Gugu used to collect her antiretrovirals from a USAID-funded clinic in central Johannesburg. But when President Trump's cuts to ...

This new FDA-approved shot is designed to break down the barriers that have kept too many people from accessing PrEP.

A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...

A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.

Six months of prevention -- that's how long Lenacapavir, the new drug for HIV prevention lasts.The Food and Drug Administration approved it last month, and desp ...

If approved, doravirine/islatravir would be the first two-drug HIV treatment regimen without an integrase inhibitor, ...

The Minister’s address was particularly notable for the announcement of a planned rollout of lenacapavir, a biannual ...

Gilead has partnered with Global Fund to supply lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP).

HIV jab has signed a deal to supply the costly injection at a knock-down price to as many as two million people in poorer countries.